21595 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins; Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
Sub-classes:RADIOLABELED ANTI-PD-L1 ANTIBODIES FOR IMMUNO-PET IMAGING
#2ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#3Mouse Anti-Human Monoclonal Antibody Against Glypican-3
#4Radiolabelled Compounds
#5DIELS-ALDER CONJUGATION METHODS
#6THERAPEUTIC AGENTS AND USES THEREOF
#7NANOBODY BASED IMAGING AND TARGETING OF ECM IN DISEASE AND DEVELOPMENT
#8PEPTIDE LINKERS FOR CONSTRUCTION AND REDUCING AGGREGATION OF FUSION POLYPEPTIDES COMPRISING SUCH
#9ANTIBODY MONO-OR MULTI-SPECIFIC TO EPHRIN TYPE-A RECEPTOR 10, CHIMERIC ANTIGEN RECEPTOR T-CELL EXPRESSING THE SAME AND USES THEREOF
#10METHOD FOR PRODUCING FC-CONTAINING MOLECULE MODIFYING REAGENT
#11PROTEINS HAVING A COVALENT WARHEAD
#12HER3 NANOBODIES
#13BINDING PROTEIN
#14CD3 TARGETING ANTIBODIES AND USES THEREOF
#15RADIOIMMUNOCONJUGATES TARGETING PHOSPHATIDYLSERINE FOR USE IN THE TREATMENT OF CANCER
#16RADIOIMMUNOCONJUGATES AND THERAPEUTIC USES THEREOF
#17HUMANIZED HH1
#18IMMUNOCONJUGATES COMPRISING KALLIKREIN RELATED PEPTIDASE 2 ANTIGEN BINDING DOMAINS AND THEIR USES
#19RADIOPHARMACEUTICALS WITH HIGH STABILITY AND RADIOLABELING EFFICIENCY AND THERANOSTIC KIT COMPRISING SAID RADIOPHARMACEUTICALS
#20ANTIBODY-DRUG CONJUGATES COMPRISING HUMANIZED ANTIBODIES TARGETING UROKINASE TYPE PLASMINOGEN ACTIVATOR RECEPTOR ASSOCIATED PROTEIN (UPARAP)
#21GRP78 NANOBODIES
#22DIMERIC IMMUNOCONJUGATES FOR USE IN TREATING CANCERS AND METHODS OF USE
#23AGENTS FOR TREATMENT OF ENDOMETRIOSIS AND OTHER BENIGN GYNECOLOGICAL NEOPLASMS
#24SCISSION-ENHANCED NUCLEAR IMAGING AND TREATMENT
#25METHOD FOR PROVIDING A LABELED SINGLE ISOMERIC CHEMICAL ENTITY TARGETING VECTOR BASED ON THE USE OF AN ISOMER-FREE DIENOPHILE
#26MACROCYCLIC COMPOUNDS AND DIAGNOSTIC USES THEREOF
#27Methods for Biological Material Labeling and Medical Imaging
#28CELL-SURFACE ANTIBODY TO A SPECIFIC BIOMARKER OF PANCREATIC BETA-CELLS
#29ANTI-Ly6E ANTIBODIES, IMMUNOCONJUGATES, AND USES THEREOF
#30METHODS FOR TREATING CANCER USING COMBINATIONS OF PARP INHIBITORS AND ANTIBODY RADIOCONJUGATES
#31EGFR-CMET-TARGETED COMPOUNDS AND USES THEREOF
#32ANTIBODY-PEPTIDE FUSION PROTEINS FOR TREATING AMYLOID DISORDERS
#33LABELED PROBE AND METHODS OF USE
#34HIGH AFFINITY B7-H6 ANTIBODIES AND ANTIBODY FRAGMENTS
#35MACROCYCLE CONTAINING COMPOUNDS AND RADIOLABELLED COMPLEXES THEREOF, AS LIGANDS IN TARGETED RADIOTHERAPY APPLICATIONS
#36Fluorescently Labeled Immunoglobulin Single Variable Domains
#37PHARMACEUTICAL COMPOSITION CONTAINING TAGGED SITE-ANTIHUMAN ANTIBODY FAB FRAGMENT COMPLEX
#38STEAP2-TARGETED COMPOUNDS AND USE THEREOF
#39RADIOLABELED ANTI-PD-L1 ANTIBODIES FOR IMMUNO-PET IMAGING
#40LABELING OF ANTIBODIES
#41LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME
#42BIFUNCTIONAL CHELATORS AND CONJUGATES
#43CHELATORS FOR RADIOMETALS AND METHODS OF MAKING AND USING SAME
#44RADIOIMMUNOCONJUGATES DIRECTED TO NKG2D LIGANDS FOR THE TREATMENT OF CANCER
#45DIELS-ALDER CONJUGATION METHODS
#46A DELTA-OPIOID RECEPTOR TARGETED AGENT FOR MOLECULAR IMAGING AND IMMUNOTHERAPY OF CANCER
#47METHODS AND COMPOSITIONS RELATED TO ANTIBODY FRAGMENTS THAT BIND TO TUMOR-ASSOCIATED GLYCOPROTEIN 72 (TAG-72)
#48BIOACTIVE SUBSTANCE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF
#49Bifunctional chelators and conjugates
#50GALLIUM 68 LABELED AFFIBODY PROTEIN PET IMAGING AGENT AND USE THEREOF
#51Antibody-peptide fusion proteins for treating amyloid disorders
#52ANTIBODIES
#53ANTI-PSMA ANTIBODIES AND USES THEREOF
#54NUCLEIC ACIDS ENCODING HUMAN ANTIBODIES TO SIALYL-LEWIS A
#55NANOBODY BASED IMAGING AND TARGETING OF ECM IN DISEASE AND DEVELOPMENT
#56ANTIBODY FRAGMENT AGAINST FOLR1
#57MATERIALS AND METHODS FOR TREATING CORONAVIRUS
#58IN VIVO IMMUNOIMAGING OF INTERFERON-GAMMA
#59DR5 RADIOIMMUNOTHERAPY IN THE TREATMENT OF SOLID CANCERS
#60RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY
#61COMPOSITIONS INCLUDING EX VIVO ARMED T CELLS WITH MULTI-SPECIFIC ANTIBODIES AND USES THEREOF
#62NON-INTUITIVE COMBINATION OF DRUG DELIVERY CARRIERS OF THE SAME DRUG FOR SYNERGISTIC GROWTH DELAY OF SOLID TUMORS
#63CD8 BINDING AGENTS AND USES THEREOF
#64ANTI-CD103 ANTIBODIES
#65ENGINEERED ANTI-PROSTATE STEM CELL ANTIGEN FUSION PROTEINS AND USES THEREOF
#66IMMUNOTHERANOSTIC AGENT TARGETING MESENCHYMAL STEM CELL-DERIVED CANCER CELLS AND MESENCHYMAL STEM CELL ASSOCIATED DISEASE
#67COMPOUNDS FOR FAST AND EFFICIENT CLICK RELEASE
#68Macrocyclic Chelators and Methods of Use Thereof
#69IGF-1R MONOCLONAL ANTIBODIES AND USES THEREOF
#70NANOPARTICLE IMMUNOCONJUGATES
#71Urokinase Plasminogen Activator Receptor-Targeted Radiopharmaceutical
#72BIOCOMPATIBLE POLYMERIC DRUG CARRIERS FOR DELIVERING ACTIVE AGENTS
#73Diels-alder conjugation methods
#74RADIOLABELLED ANTIBODY FRAGMENTS FOR USE IN TREATING CANCER
#75IMMUNOPET AND IMMUNOSPECT IMAGING TO IDENTIFY CYTOTOXIC T CELL ACTIVITY
#76ADMINISTRATION OF THERAPEUTIC AGENTS TO BRAIN AND OTHER CELLS AND TISSUE
#77ADDITIONAL MASS TAG POLYMERS FOR MASS CYTOMETRY
#78IN VIVO IMMUNOIMAGING OF INTERLEUKIN-12
#79Low dose antibody-based methods for treating hematologic malignancies
#8018F-RADIOLABELED BIOMOLECULES
#81Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging
#82COMPOUNDS AND METHODS FOR THE DETECTION OF TRPV-6 CANCERS AND DRUG DELIVERY
#83Bifunctional do2pa derivatives, chelates with metallic cations and use thereof
#84RADIO-PHARMACEUTICAL COMPLEXES
#85HER3 RADIOIMMUNOTHERAPY FOR THE TREATMENT OF SOLID CANCERS
#86THERAPEUTIC AGENTS AND USES THEREOF
#87COMBINATION OF AR ANTAGONISTS AND TARGETED THORIUM CONJUGATES
#88Anti-PD-L1 diabodies and the use thereof
#89RADIOIMMUNOCONJUGATES AND DNA DAMAGE AND REPAIR INHIBITOR COMBINATION THERAPY
#90Actinium-225 and checkpoint inhibitor combination therapy
#91C-terminal lysine conjugated immunoglobulins
#92Methods for Treating Cancer Using Combinations of PARP Inhibitors and Antibody Radioconjugates
#93Labeled probe and methods of use
#94REAGENT FOR BIOCONJUGATION VIA IRREVERSIBLE REBRIDGING OF DISULFIDE LINKAGES
#95PHARMACEUTICAL PREPARATION
#96MACROCYCLIC CHELATES AND USES THEREOF
#97COMPOSITIONS TARGETING THE SOLUBLE EXTRACELLULAR DOMAIN OF E-CADHERIN AND RELATED METHODS FOR CANCER THERAPY
#98Pharmaceutical composition containing tagged site-antihuman antibody fab fragment complex
#99RADIOFLUORINATED GPC3-BINDING PEPTIDES FOR PET IMAGING OF HEPATOCELLULAR CARCINOMA
#100Complex having anti-human MUC1 antibody Fab fragment, peptide linker and/or ligand
#101High affinity B7-H6 antibodies and antibody fragments
#102Method of treating autoimmune inflammatory crohn's disease
#103N-acetylgalactosamino dendron-clearing agent for dota-pretargeted radioimmunotherapy
#104RADIO-PHARMACEUTICAL COMPLEXES
#105RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY
#106Anti-IL1RAP antibodies and their use for treating humans
#107METHOD FOR OPTICAL OPENING OF THE BLOOD-BRAIN BARRIER
#108Targeted Self-Assembly of Functionalized Carbon Nanotubes on Tumors
#109SYNERGISTIC ANTI-CD47 THERAPY FOR HEMATOLOGIC CANCERS
#110Modified antibody and radioactive metal-labelled antibody
#111Residualizing linkers and uses thereof
#112KIT TECHNOLOGY FOR THE PRODUCTION AND LONG-TERM STORAGE OF ZR-89-PET RADIOPHARMACEUTICALS
#113POSITRON EMISSION TOMOGRAPHY IMAGING OF ACTIVATABLE BINDING POLYPEPTIDES AND RELATED COMPOSITIONS THEREOF
#114CKIT antibody drug conjugates
#115Macrocyclic chelators and methods of use thereof
#116NANOPARTICLE IMMUNOCONJUGATES
#117RADIOLABELED ANTI-PD-L1 ANTIBODIES FOR IMMUNO-PET IMAGING
#118Treatment and diagnosis of inflammatory disorders and HIV
#119Anti-human MUC1 antibody Fab fragment
#120Methods and compositions related to antibody fragments that bind to tumor-associated glycoprotein 72 (TAG-72)
#121NUCLEIC ACIDS ENCODING HUMAN ANTIBODIES TO SIALYL-LEWIS A
#122In vivo immunoimaging of interferon-gamma
#123ANTI-MESOTHELIN RADIOLABELLED SINGLE DOMAIN ANTIBODIES SUITABLE FOR THE IMAGING AND TREATMENT OF CANCERS
#124NOVEL ANTI-HUMAN MUC1 ANTIBODY FAB FRAGMENT
#125THERAPEUTIC AGENTS AND USES THEREOF
#126ANTIBODY DRUG CONJUGATES
#127Anti-human CEACAM5 antibody Fab fragment
#128ANTIBODY CONJUGATE FOR TREATING AND DETECTING BLADDER CANCER
#129Internalizing human monoclonal antibodies targeting prostate and other cancer cells
#130Bifunctional do2pa derivatives, chelates with metallic cations and use thereof
#131FOXC1 ANTIBODIES AND METHODS OF THEIR USE
#132C-terminal lysine conjugated immunoglobulins
#133COMPOSITIONS TARGETING THE SOLUBLE EXTRACELLULAR DOMAIN OF E-CADHERIN AND RELATED METHODS FOR CANCER THERAPY
#134Anti-human MUC1 antibody Fab fragment
#135RADIO-PHARMACEUTICAL COMPLEXES
#136Compositions for therapeutics, targeted PET imaging and methods of their use
#137Methods for the iodination of biomolecules
#138Low dose antibody-based methods for treating hematologic malignancies
#139Anti-CLL-1 antibodies and immunoconjugates
#140Nanobody based imaging and targeting of ECM in disease and development
#141Compounds and methods for the detection of TRPV-6 cancers and drug delivery
#142Treatment and diagnosis of inflammatory disorders and HIV
#143High affinity B7-H6 antibodies and antibody fragments
#144Radio-pharmaceutical complexes
#145Radiolabeled drug
#146IGF-1R monoclonal antibodies and uses thereof
#147Humanized Anti-HLA-DR Antibodies
#148SYNERGISTIC ANTI-CD47 THERAPY FOR HEMATOLOGIC CANCERS
#149ANTIBODIES
#150Compounds, compositions and associated methods using zirconium-89 in immuno-positron emission tomography
#151Isotope preparation method
#152Therapeutic antibodies and uses thereof
#153Blood-brain barrier permeable peptide compositions comprising a VAB domain of an anti-amyloid-beta camelid single-domain heavy-chain only antibody
#154Labeled probe and methods of use
#155Methods of detecting a solid tumor with anti-IL1RAP antibodies
#156Targeted self-assembly of functionalized carbon nanotubes on tumors
#157Labeling of antibodies
#158Methods for low temperature fluorine-18 radiolabeling of biomolecules
#159Extension sequences for diabodies
#160Radiolabelled antibody fragments for use in treating cancer
#161CKIT antibody drug conjugates
#162NUCLEIC ACID AND CORRESPONDING PROTEIN NAMED 158P1D7 USEFUL IN THE TREATMENT AND DETECTION OF BLADDER AND OTHER CANCERS
#163Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging
#164Systems and methods for determining optimum patient-specific antibody dose for tumor targeting
#165Nanoparticle immunoconjugates
#166Radiolabeled active targeting pharmaceutical composition and the use thereof
#167Treatment and diagnosis of inflammatory disorders and HIV
#168NON-INVASIVE IMAGING OF TUMOR PD-L1 EXPRESSION
#169Anti-CLL-1 antibodies and immunoconjugates
#170Anti-CLL-1 antibodies and immunoconjugates
#171Anti-CLL-1 antibodies and immunoconjugates
#172Functionalized linear ligands and complexes thereof
#173RADIO-PHARMACEUTICAL COMPLEXES
#174BIFUNCTIONAL do2pa DERIVATIVES, CHELATES WITH METALLIC CATIONS AND USE THEREOF
#175Isolated nucleic acid encoding an anti-IGF-1R antibody
#176Alpha-emitting complexes
#177Dual Variable Domain Immunoglobulin and Uses Thereof
#178Antibodies to GRP78
#179Anti-PMEL17 antibodies and immunoconjugates
#180Internalizing human monoclonal antibodies targeting prostate and other cancer cells
#181Methods and compositions related to antibody fragments that bind to tumor-associated glycoprotein 72 (TAG-72)
#182Actinium-225 compositions of matter and methods of their use
#183METHODS FOR IDENTIFICATION OF SITES FOR IGG CONJUGATION
#184Cage-like bifunctional chelators, copper-64 radiopharmaceuticals and PET imaging using the same
#185PROLACTIN RECEPTOR ANTAGONISTS FOR TREATMENT OF GLIOBLASTOMA
#186IMMUNO-PET IMAGING OF ANTIBODIES AND IMMUNOCONJUGATES AND USES THEREFOR
#187Bacteriophage gene 3 protein compositions and use as amyloid binding agents
#188Method of treating a solid tumor with IL1RAP antibodies
#189Humanized anti-HLA-DR antibodies
#190Antibody drug conjugates
#191Antibodies, antibody drug conjugates and methods of use
#192NUCLEIC ACIDS ENCODING HUMAN ANTIBODIES TO SIALYL-LEWIS A
#193Radiotherapeutic particles and suspensions
#194Oligopeptide and methods for producing conjugates thereof
#195Radio-imaging and radio-therapy of cancer using antibodies to HAAH
#196Treatment and diagnosis of inflammatory disorders and HIV
#197Class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type I receptor (IGF-1R)
#198Antibodies that bind OV064 and methods of use therefor
#199Anti-CD19 antibodies
#200Picolinate cross-bridged cyclams, chelates with metallic cations and use thereof
#201Residualizing linkers and uses thereof
#202Selectin ligands useful in the diagnosis and treatment of cancer
#203PHARMACEUTICAL PREPARATION
#204Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
#205NUCLEIC ACID AND CORRESPONDING PROTEIN NAMED 158P1D7 USEFUL IN THE TREATMENT AND DETECTION OF BLADDER AND OTHER CANCERS
#206Antigen associated with the neovasculature of tumour metastases
#207Anti-CLL-1 antibodies and immunoconjugates
#208Prosthetic compounds for labeling internalizing biomolecules
#209Monoclonal antibody against necrosis marker PRDX4 and use thereof
#210COMPOSITIONS TARGETING THE SOLUBLE EXTRACELLULAR DOMAIN OF E-CADHERIN AND RELATED METHODS FOR CANCER THERAPY
#211cKIT antibody drug conjugates
#212Monoclonal antibodies targeting EpCAM for detection of prostate cancer lymph node metastases
#213Method for Treating Cancers by Alternating Immunotherapeutics and Directly Oncolytic Therapeutics
#214Bacteriophage gene 3 protein compositions and use as amyloid binding agents
#215Methods and compositions for radiohalogen protein labeling
#216Anti-PMEL17 antibodies and immunoconjugates
#217Class I anti-CEA antibodies and uses thereof
#218Method and device for producing crude copper
#219Antibodies reactive with an epitope located in the N-terminal region of MUC5AC comprising cysteine-rich subdomain 2 (Cys2)
#220Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
#221Radiolabelled antibody and uses thereof
#222Radioisotope trithiol complexes
#223RECEPTOR BINDING CONJUGATES
#224Radiolabeled active targeting pharmaceutical composition and the use thereof
#225ONCOFETAL ANTIGEN/IMMATURE LAMININ RECEPTOR ANTIBODIES FOR DIAGNOSTIC AND CLINICAL APPLICATIONS
#226Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
#227Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
#228Treatment and diagnosis of inflammatory disorders and HIV
#229PSMA ANTIBODIES AND USES THEREOF
#230Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity
#231Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
#232Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
#233Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
#234Methods of treating cancer with antibodies that target the insulin-like growth factor type I receptor (IGF-1R)
#235Compounds and methods for the detection of TRPV-6 cancers and drug delivery
#236Anti-mucin antibodies for early detection and treatment of pancreatic cancer
#237Class I anti-CEA antibodies and uses thereof
#238Radio-pharmaceutical complexes
#239RADIO-PHARMACEUTICAL COMPLEXES
#240Actinium-225 compositions of matter and methods of their use
#241NUCLEOTIDE AND PROTEIN SEQUENCES OF AN ANTIBODY DIRECTED AGAINST AN EPITOPE COMMON TO HUMAN ACIDIC AND BASIC FERRITINS, MONOCLONAL ANTIBODIES OR ANTIBODY-LIKE MOLECULES COMPRISING THESE SEQUENCES AND USE THEREOF
#242FOXC1 ANTIBODIES AND METHODS OF THEIR USE
#243Methods for identification of sites for IgG conjugation
#244CX3CR1-targeting imaging agents and their use in the diagnosis and treatment of disease
#245ZIRCONIUM-RADIOLABELED, CYSTEINE ENGINEERED ANTIBODY CONJUGATES
#246Dual Variable Domain Immunoglobulin and Uses Thereof
#247SYNERGISTIC ANTI-CD47 THERAPY FOR HEMATOLOGIC CANCERS
#248Bacteriophage gene 3 protein compositions and use as amyloid binding agents
#249Antibodies for molecular imaging of vulnerable plaques in atherosclerosis
#250Antibodies that bind OV064 and methods of use therefor
#251Treating macular degeneration using antibodies to aminophospholipids
#252Anti-B7-H4 antibodies and immunoconjugates
#253Antibodies to TIP-1
#254Targeted self-assembly of functionalized carbon nanotubes on tumors
#255Therapeutic agents and uses thereof
#256PSMA antibodies and uses thereof
#257Antibody drug conjugates
#258Internalizing human monoclonal antibodies targeting prostate and other cancer cells
#259Immuno imaging agent for use with antibody-drug conjugate therapy
#260Anti-mucin antibodies for early detection and treatment of pancreatic cancer
#261Humanized anti-HLA-DR antibodies
#262Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
#263BISPECIFIC ANTIBODIES AGAINST HER2
#264Methods and compositions for radiohalogen protein labeling
#265Radioimunoconjugates and uses thereof
#266Humanized L243 antibodies
#267Anti-CD19 antibodies
#268Pretargeting kit for imaging or therapy comprising a trans-cyclooctene dienophile and a diene
#269Tc imaging agents and methods of use
#270NUCLEIC ACID AND CORRESPONDING PROTEIN NAMED 158P1D7 USEFUL IN THE TREATMENT AND DETECTION OF BLADDER AND OTHER CANCERS
#271NUCLEIC ACID AND CORRESPONDING PROTEIN NAMED 158P1D7 USEFUL IN THE TREATMENT AND DETECTION OF BLADDER AND OTHER CANCERS
#272Method of treatment of a solid tumor with interleukin-1 accessory protein antibody
#273COMBINATORIAL THERAPY
#274MISFOLDED PROTEINS IN CANCER TREATMENT AND DIAGNOSIS
#275Anti-PMEL17 antibodies and immunoconjugates
#276Agents for clearing biomolecules from circulation
#277Anti-CEACAM6 antibodies and uses thereof
#27899mTc IMAGING AGENTS AND METHODS OF USE
#279Pretargeting kit, method and agents used therein
#280Alpha-emitting complexes
#281Anti-CD74 immunoconjugates and methods of use
#282Bladder cancer tumor marker, antibody and use thereof
#283Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
#284Antibody against carcinoembryonic antigen and uses thereof
#285Anti-CD19 antibodies
#286Structural Variants of Antibodies for Improved Therapeutic Characteristics
#287Radioactive metal-labeled anti-cadherin antibody
#288Antibodies that bind OV064 and methods of use therefor
#289Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
#290Antigen associated with the neovasculature of tumour metastases
#291Monoclonal antibody against necrosis marker ERP29 and use thereof
#292Class I anti-CEA antibodies and uses thereof
#293Polyazamacrocyclic compound, and a production method and a biomedical use therefor
#294Dual Variable Domain Immunoglobulin and Uses Thereof
#295Monoclonal antibody against necrosis marker PRDX4 and use thereof
#296Radioimmunoconjugates and uses thereof
#297Synergistic anti-CD47 therapy for hematologic cancers
#298Bifunctional polyazamacrocyclic chelating agents
#299Treatment and diagnosis of inflammatory disorders and HIV
#300Peptide Conjugates Comprising Polyhistidine Sequence and Free Cysteine and Their Uses in Imaging